IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, announced today that it has won the 2024 Pharmaceutical Technology Excellence Awards’ Brand Leadership category for its “Timing is Everything” campaign. The campaign features IFF’s newly designed controlled release platform, which provides customers with solutions at every turn.
This award recognizes “Timing is Everything” campaign for its strategic marketing tactics, creativity and leadership. The campaign focuses on building an integrated thought leadership platform for controlled release through storylines and cohesive branding. It includes a three-pronged approach with a social media teaser countdown, video and microsite.
“We are honored to receive this esteemed recognition for our ‘Timing is Everything’ campaign that highlights our controlled release portfolio,” said Lisa M. Miree-Luke, global communications director, IFF Pharma Solutions. “This award is a testament to our trailblazing products and the passionate teams behind them. METHOCEL™─Pioneering Then, Innovating Now; ETHOCEL™─Proven Time After Time and POLYOX™─Versatile Across Complex and Unique Applications, they are not just taglines but promises we stand by. We are committed to driving innovation, quality and helping to enable our customers’ successes.”
The Pharmaceutical Technology Excellence Awards honors the most significant achievements and innovations in the pharmaceutical industry. Powered by GlobalData’s business intelligence, the awards recognize the people and companies leading change and shaping the future of the industry.
New York-based IFF began Tuesday morning trading up 18 cents to $83.47.
